Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
SONG, YANG
NCT04840290: A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC	Recruiting	3	30	RoW	Biological: Sintilimab Drug: Cisplatin Drug: Paclitaxel for Injection (Albumin Bound) Drug: Carboplatin	Tang-Du Hospital	Non Small Cell Lung Cancer	06/23	06/23
NCT05231668: Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)	Terminated	1	16	Europe, Canada, US, RoW	SAR439459, Placebo	Sanofi	Osteogenesis Imperfecta	11/24	11/24
NCT04714489: Public Title：A Study on the Registration of The Use of Feilike HeJi in Adults	Recruiting	N/A	3000	RoW	NO.	China Academy of Chinese Medical Sciences	Bronchial Asthma	06/21	08/21